1[1]Perry CM, Lamb HM. Topical imiquimod: A review of its use in genital warts[J]. Drugs, 1999,58(2):375-390.
2[2]Ormrod D, Scott LJ, Perry CM. Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections[J]. Drugs, 2000,59(4):839-863.
3[3]Alper BS, Lewis PR. Does treatment of acute herpes zoster prevent or shorten postherapetic neuralgia?[J] J Fam Pract, 2000,49(3):255-264.
4[4]Ioannides D, Chrysomallis F, Bystryn JC. Ineffectiveness of cyclosporine as an adjuvant to corticosteroids in the treatment of pemphigus[J]. Arch Dermatol, 2000,136(7):868-872.
5[5]David M, Darin S, Gogstetter, et al. Minocycline-induced hyperpigmentation in patients with pemphigus and pemphigoid[J]. Arch Dermatol, 2000,136(9):1133-1138.
6[6]Kyriakis KP, Kontochristopoulos GJ, Panteleos DN. Experience with low-dose thalidomide therapy in chronic discoid lupus erythematosus[J]. Int J Dermatol, 2000,39(3):218-222.
7[7]Boyvat A, Siman-solak C, Gǘ rler A. Long-term effects of interferon alpha 2A treatment in Behcet's disease[J]. Dermatology, 2000,39(3):218-222.
8[8]Alpsoy E, Er H, Durusoy C, et al. The use of sucralfate suspension in the treatment of oral and genital ulceration of Behcet s disease[J]. Arch Dermatol, 1999,135(5):529-532.
9[9]Trautinger F. Low-dose 2-chloro-deoxyadenosine for the treatment of mycosis fungoides[J]. Arch Dermatol, 1999;135(5):1279-1280.
10[10]Clark C, Dawe DS, Evans AT, et al. Narrowband TL-01 phototherapy for patch-stage mycosis fungoides[J]. Arch Dermatol, 2000,136(6):748-753.
